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Epstein-Barr  virus  (EBV) 1 is  a  herpes-type virus  that  infects B  lymphocytes in 
humans and other primates (1). It is the causative agent of infectious mononucleosis 
(2), and is associated with certain human B cell tumors, such as Burkitt's lymphoma 
(1, 3). EBV can polyclonally activate human B lymphocytes to immunoglobulin (Ig) 
secretion (4-6). This polyclonal activation, which is readily seen following the infection 
of human B cells by EBV in vitro, does not require the activity of either T  cells or 
macrophages  (5,  7).  Therefore, EBV  has shown  great  potential  for use as a  direct 
polyclonal B cell activator (PBA) for human B cells. Because of this, knowledge of the 
frequency of human B cells that can be activated to Ig secretion by EBV is not only 
of  interest  in  understanding  more  about  the  interactions  of  EBV  with  human 
lymphocytes, but is essential in interpreting the results obtained when EBV is used as 
a PBA in studies on the immune potential of human B cells. 
Here we  present  a  quantification  of the  EBV-induced  polyclonal  activation  of 
human B cells to Ig secretion. This was done by limiting dilution analysis of EBV- 
activated human B ceils, to determine the precursor frequency (PF) of IgM and IgG- 
secreting cells. Limiting dilution analysis of murine B cells has been used to determine 
the frequency of B cells activatable by antigens or mitogens (8, 9). This technique has 
also been used to quantify the response of human B cells to pokeweed mitogen (PWM) 
(10). 
In this report, the PF of IgM-secreting cells induced by EBV is compared to that 
induced by a commonly used, T  cell-dependent PBA, PWM. Both EBV and PWM 
appeared to activate a  small fraction of human B cells to IgM secretion, and these 
two PBA apparently acted on discrete B cell subpopulations. 
Materials and Methods 
Cell Preparation.  Mononuclear leukocytes were separated  from the blood of healthy  adult 
donors by centrifugation of the buffy coat traction of citrate blood, diluted 1  : 1 (vol/vol) with 
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Abbreviations  used  in  this paper:  EBV, Epstein-Barr virus;  Hepes,  N-2-hydroxyethyl-piperazine-N'-2- 
ethanesulphonic  acid; Ig, immunoglobulin;  PBA, polyclonal B cell activator; PF, precursor frequency; 
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sterile saline, over Lymphoprep (Nyegaard & Co., A/S, Oslo, Norway) gradients (11). 
T  and  B  Lymphocyte Separation.  T  and  B  cells  were  fractionated  by erythrocyte  rosette 
separation (12). Briefly, lymphocytes were allowed to form rosettes  with sheep erythrocytes 
(SRC) by incubating at 37°C for 15 rain, centrifuging at 200g for 5 min at 20°C, then being 
kept  at 4oC for  1-2 h. Rosette-forming cells were then separated from nonrosetted cells  by 
centrifugation over Lymphoprep gradients (500 g  for 25-30 min, at  20°C).  B cell  fractions 
(nonrosette-forming cells) contained <5% SRC-binding cells and ~50% surface membrane Ig 
positive (smlg+)  cells,  as  measured by direct immunofluorescence (13-15).  T  cell fractions 
(SRC-rosetting cells) contained < 10% nonrosette-forming  cells and <7% smlg+ cells. When the 
T  cell fractions were irradiated, this was done by exposing these cells to 2,000 R  y-radiation, 
before their use as filler cells. In experiments where nonirradiated T  cells were used as filler 
cells, the T cell fraction was passed through nylon-wool columns two times before use (16). 
Tissue Culture.  Cells were cultured in 12 mm ×  75 mm polystyrene test tubes (No.  2058, 
Falcon, Oxnard, CA), containing  0.2 ml of RPMI 1640 medium, supplemented with 10% heat- 
inactivated human AB serum, antibiotics (100 IU/ml penicillin and 100 #g/ml streptomycin), 
10  mM  Hepes  buffer,  and  sodium  bicarbonate  (25  mM).  Cultures  were  incubated in  a 
humidified atmosphere, containing 5% COs, at 37°C for 7 d. 
Viral Exposure of Cells.  EBV-containing  supernatant, from the B95-8 marmoset cell line (the 
kind gift of Dr.  George Klein) (17),  was used as  the source of virus. This virus-containing 
supernatant was  filtered  (0.45-#m  pore size)  before  use.  Viral exposure was  performed  by 
suspending cells in the B95-8 supernatant at a concentration of 5 ×  l0  s to 1 ×  10  7 cells per ml 
ofsupernatant, and incubating  for 1 h at 37°C (5-7). After exposure, the cells were washed two 
times and placed in the final culture medium at an appropriate cellular concentration. Cells 
were exposed to PWM (Techtum, Uppsala, Sweden) by continuous contact with this agent in 
culture, at  a  concentration of 20 /zg/ml.  Cells were  exposed  to cyclosporin-A (200  ng/ml, 
Sandoz, Ltd., Basel, Switzerland) similarly. 
Protein-A Plaque Assay.  The assay used to enumerate Ig-secreting cells was a modification of 
that developed by Gronowicz and co-workers  (18), and was performed as previously described 
(5-7). Briefly,  25/.d of optimally diluted rabbit anti-human-D-chain (1:60,  vol/vol) or anti- 
human-y-chain (1:100, vol/vol) sera (DAKO Immunoglobulins  A/S, Copenhagen, Denmark) 
was mixed with 100/d of a lymphocyte suspension, 25/xt  12% (vol/vol) protein-A SRC, 25/zl 
SRC-absorbed guinea pig complement (Flow Laboratories, Irvine, Scotland), and 200/~1 0.5% 
agar (Bacto-Agar, Difco Laboratories Inc., Detroit, MI) containing  0.05% DEAE-Dextran, and 
poured on 15 mm ×  100-ram plastic dishes, and covered with 24 mm ×  32 mm glass coverslips. 
This mixture was allowed to gel, and incubated at 37°C in a humidified atmosphere for 3-4 h 
before plaques were counted. Lymphocyte preparations were washed three to four times before 
being assayed. 
Analysis of Experimental Results.  PF estimates, for human B cells stimulatable to secrete  IgM 
or IgG, were calculated by Poissonian analysis of the data obtained from limiting dilution 
experiments, as described by Lefkovits and Waldmann (9). Least-squares analysis was used to 
obtain the line of best fit. In preliminary experiments, 4 to 5 cell dilutions with from 6 to  10 
cultures per dilution were used. In final experiments, typically from  18 to 21  cultures were 
analyzed at each of 5 to 6 cell dilutions (varying from 30,000 to 100 B cells per culture). Values 
for r  (a measure of the "fit" of the line to the experimental results; a  value of 1 indicates a 
perfect fit,  one of <0.95 was taken to indicate unacceptable fit)  in final experiments ranged 
from  0.955  to  0.999+.  Values for ),-intercept  (a  measure of where  the  line of best  fit,  as 
calculated by least-squares analysis, intercepts the ),-axis; a value of 1 is ideal) ranged from 0.88 
to  1.10. All final experiments were found to conform to single-hit kinetics, when analyzed by 
the X  3 test (9). Clone size estimates were obtained using the method described by Lefkovits and 
Waldmann (9), using the formula: 
Y~PFC 
C  -- 
?l 
where c is the clone size, ~PFC is the sum of the PFC seen in the responding cultures, and n is 
the calculated number of clones present at a given cell dilution. 
Positive cultures were defined as cultures showing >4 PFC, a level greater than three standard 1810  FREQUENCIES  OF  B  CELLS  ACTIVATABLE  BY  EPSTEIN-BARR  VIRUS 
deviations above the mean value of PFC seen in cultures containing only filler cells, or no cells 
at all. No positive cultures were seen in groups containing only filler cells, For all calculations, 
B  cell fractions were assumed to contain 50% B  cells. 
Results 
Optimization  of Microculture Conditions.  Since it is important that culture conditions 
allow the growth of all, or most, inducible cells to cells secreting Ig, various culture 
conditions  were tested  to determine which  were optimal for the EBV- and  PWM- 
induced polyclonal activation of human B cells to Ig secretion. Pilot experiments were 
designed  to  determine  whether  filler cells were  required  for optimal  PF  estimates. 
Autologous T  cells  (nylon-wool purified),  cyclosporin A-treated autologous T  cells, 
and irradiated autologous T  cells were added to the B cell fraction, and the frequency 
of stimulatable B cells was compared to that seen when B cells were cultured without 
the addition of filler cells. Activation with EBV did not require the presence of filler 
cells for optimal PF estimates (Table I). However, PWM  activation did require the 
presence of filler T  cells (Table I). Interestingly, the use of nonirradiated, autologous 
T  cells as filler cells led to a marked decrease in the observed EBV-activated IgM PF 
(Table I); this decrease was partially corrected by culturing cells in the presence of 
cyclosporin-A, and completely corrected by irradiation  of the T  cells used as fillers 
(Table I). Other sources of filler cells were tested (cord blood T  cells and allogeneic T 
cells), and found not to provide better conditions for the growth of activated B cells 
to Ig-secreting cells than autologous, irradiated T  cells (data not shown). On the basis 
of these  results,  irradiated,  autologous  T  cells  were  used  as  filler  cells  in  all  final 
limiting dilution  experiments, when human  B  cells were activated by EBV and/or 
PWM. 
The Precursor Frequency of EBV-Activated Human B Cells for IgM and IgG Secretion.  The 
determination of the PF of human B  cells, activated by exposure to EBV,  for IgM 
and IgG secretion, was carried out under more stringent conditions than used for the 
pilot experiments described above. Approximately 20 cultures were tested per B cell 
dilution,  with  5-6  dilutions  assayed  per  PF  determination.  The  results  of these 
TABLE  I 
Precursor Frequencies  for IgM Secretion by Human B Cells; Results of Preliminary Experiments 
Cells placed in culture 
B only*  B +  "I  ~  B +  T  +  cy-  B +  Irradi- 
closporin-A  §  ated T I 
EBV-Driven  IgM  precursor  fre-  0.000391  0.000047  0.00014  0.00065 
quency  :t:0.00020  +  0.000003  +  0.00005  ±  0.00008 
(1/2,660)'"  (1/21,000)  (1/7,100)  (1/1,500) 
PWM-Driven  IgM  precursor  fre-  <0.0000025  0.00059 
quency  --  --  ±  0.00050 
(<11400,000)  (111,700) 
* B cells are non-SRC-rosette-forming cells. 
# T cells are SRC-rosette-forming cells that have been passed through nylon-wool columns twice. 
1200 ng/ml cyclosporin-A. 
|  2,000 rads. 
1 All values are the mean :t: standard error of the mean of two to three independent determinations of 
precursor frequency. 
** The fractional equivalent of the mean decimal precursor frequency estimate shown. MARTINEZ-MAZA  AND  BRITTON  1811 
experiments are shown in Table II; the data from one experiment is plotted in Fig.  1 
to illustrate how the experimental data were analyzed. From 1/290 to 1/2,000 B cells 
were seen  to  be  precursors  for the  secretion of IgM;  from  1/920  to  1/3,250  were 
precursors for the secretion of IgG. Clone sizes, calculated by the method of Lefkovits 
and Waldmann  (9), varied from 7.0 to 8.8 PFC per precursor for IgM, and from  13 
to 22 PFC per precursor for IgG secretion, indicating that the rate of cellular division 
required to lead to such clone sizes falls within the expected range. 
The Precursor Frequency of EB V- and PWM-activated Human B Cells  for IgM Secretion.  In 
order  to  find  whether  PWM  activated  a  similar  fraction  of human  B  ceils  to  Ig 
secretion, we  compared  the  PF  of B  ceils  activated  by EBV  to  that  activated  by 
PWM,  for IgM  secretion. The calculated PF estimates  from such experiments are 
shown  in  Table  III.  About  20  cultures  per  B  cell  dilution  and  5  dilutions  per 
determination were used. 
In the first experiment done, EBV and  PWM  activated comparable fractions of 
human B cells to IgM secretion, with IgM PF of-1/1,000 (Table III, Experiment 1). 
TABLE  II 
Precursor Frequencies of EBV-Actioated Human B Cells  for the Secretion of 
IgM and IgG 
B cell precursor frequency* 
IgM  IgG 
Experiment 1'  0.00342  0.000307 
(t/290)  ~  (1/3,250) 
Experiment 2  0.000505  0.00108 
(1/2,000)  (1/920) 
* Calculated by the method of Lefl~ovits and Waldman (9): see Materials and 
Methods section. 
* Calculated from the data presented in Fig.  1. 
! The fractional equivalent of the decimal precursor frequency estimate shown 
directly above it. 
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Fro.  l.  Limiting dilution analysis of EBV-activated human peripheral blood B lymphocytes. Total 
IgM PFC  (~--------) and IgO PFC  ~--)  responses were determined using the indirect protein-A 
plaque assay technique (18). The calculated precursor frequencies are shown (1/290 for IgM, and 
1/3,300 for IgG secretion), r values were 0.994 for IgM, and 0.999+ for IgO; y-intercepts were 0.88 
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TABLE III 
The Precursor Frequencies of EBV- and PWM-Activated  Human B CeUs  for IgM Secretion 
IgM B cell precursor frequency* 
EBV + PWM-Ac-  EBV-Activated  PWM-Activated  tivated 
Experiment 1  0.000855  0.000971  -- 
0/1,200)*  (1/1,000)  -- 
Experiment 2  0.00167  0.00735  0.010 
(1/600)  (1/140)  (1/100) 
Experiment 3  0.000267  0.000310  0.000403 
(1/3,700)  (1/3,200)  (1/2,500) 
* Calculated using the method of Lefkovits and Waldmann (9): see Materials and Methods section. 
*  The fractional equivalent of the decimal precursor frequency estimate shown above it. 
Since EBV and PWM seemed to activate a  similar number of precursors to secrete 
IgM,  experiments  were  carried  out  to  determine  if they operated  on  the  same  or 
different  B cell subpopulation.  B cells isolated from the same donor were activated 
with  EBV,  PWM,  or  EBV +  PWM,  and  placed  in  limiting  dilution  cultures  and 
assayed as described above (Table III, Experiments 2 and 3). If these two PBA were 
operating on the same subpopulation of B cells,  the expected EBV +  PWM IgM PF 
should  equal  the  EBV  or  PWM  IgM  PF  (whichever  was  greater).  If they  were 
operating on different  B cell subpopulations, the combined EBV +  PWM IgM PF 
should equal the sum of the EBV IgM PF and the PWM IgM PF. An intermediate 
result  would  indicate  that  the  EBV  and  PWM  stimulatable  subpopulations  over- 
lapped. The observed EBV +  PWM IgM PF was seen to be approximately equal to 
the sum of the separate,  EBV- and PWM-activated IgM PF (Table III), indicating 
that EBV and PWM appear to have activated different B cell subpopulations. 
Discussion 
In  searching  for  the  optimal  culture  conditions,  we  have  found  that,  for  the 
activation of human B cells  by EBV, no addition of autologous T  cells  was needed 
(Table  I).  In  fact,  if taken  from  EBV-immune  individuals,  addition  of such  cells 
(nonirradiated) decreased the observed PF by nearly a factor of 10. This is compatible 
with Thorley-Lawson's data (19) on this point, which says that if T  cells  are present 
from the start of EBV exposure to autologous B cells,  they interfere with activation. 
We have reason to assume that this negative effect of T  cells  on EBV activation of 
human B cells can be made quantitative, and thus used to determine the frequencies 
of anti-EBV specific T  cells.  In addition, we observed that this negative influence of 
live T  ceils is abolished if the cells are irradiated in vitro, but only partially abolished 
if they are exposed to cyclosporin A  (Table I). 
At first glance, the frequency of human B cells induced to Ig secretion by EBV may 
seem  low,  especially  when  compared  to  frequencies  reported  for  Ig  secretion  by 
polyclonally activated murine spleen B cells  (8). However, similar  frequencies have 
been reported for PWM-induced Ig secretion by human peripheral blood B cells  (10), 
even though these figures were obtained using a  different experimental system. The 
observed PF and clone size  estimates  for IgM and IgG secretion by EBV-activated 
human peripheral  blood B  cells  correlate well with  the  PFC  response of these cells MARTINEZ-MAZA AND BRITTON  1813 
when cultured in nonlimiting conditions (5, 6). 
We assume, at this point, that these polyclonal activators can only drive a small (1/ 
100  to  1/5,000)  subpopulation  of peripheral blood B  ceils, which are at  a  certain 
maturational  stage,  to Ig synthesis and  secretion. As  virtually every human  B  cell 
exposed to EBV in vitro is indeed infected by the virus, and accordingly expresses the 
viral antigens intranuclearly (5, 6), the point of decision to go towards Ig secretion 
must be somewhere beyond these steps in viral infection. 
The similar magnitude of the EBV- and PWM-activatable cell PF (Table III) led 
us to question whether these PBA operate on the same B cell subpopulation, what 
could be called an  "activatable B  cell subpopulation", or whether they operate on 
separate,  or  partially  overlapping  subpopulations.  Human  B  cells  activatable  by 
PWM have been shown to represent a distinct subpopulation (20, 21). To answer this 
question, B cells activated by EBV, PWM, and EBV together with PWM  (EBV + 
PWM) were cultured under limiting dilution conditions (Table III). Since the EBV 
+  PWM IgM PF was approximately equal to the sum of the separate EBV and PWM 
IgM PF, we have concluded that these PBA operate on separate B cell subpopulations. 
However, the possibility that a  small fraction of PWM-activatable cells can also be 
activated by EBV cannot, with certainty, be excluded. 
These data  shed  light  on  the  repeated  observations that  EBV  infection in  vivo 
results in a  polyelonal Ig response that has a  different specificity pattern than other 
infectious or noninfectious conditions associated with a polyclonal Ig response. 
Summary 
We have developed a microculture system suitable for limiting dilution analysis of 
Epstein-Barr  virus  (EBV)-  and  pokeweed  mitogen  (PWM)-induced  activation  of 
immunoglobulin secretion by human B cells. It was found that exogenous filler cells 
were not required to obtain optimal EBV-induced B cell precursor frequency (PF) 
estimates, although filler T  cells were required for optimal PWM activation. In fact, 
when  autologous T  cells were used  as  filler cells,  a  marked  decrease in  the  EBV- 
induced IgM  PF was noted. Treatment of the T  cells with cyelosporin A  partially 
eliminated, and irradiation of the T  cells completely eliminated, this decrease. 
The calculated PF of B cells activated by EBV was from 1/290 to 1/3,700 for IgM, 
and from 1/920 to 1/3,250 for IgG secretion. PWM activated from 1/140 to 1/3,200 
B cells to IgM secretion. The results of experiments in which EBV and PWM were 
mixed,  indicated  that  these  two  polyclonal activators operated on  different B  cell 
subpopulations. Therefore, both these agents seem to activate small, discrete subpop- 
ulations of human peripheral blood B cells to Ig secretion. 
Note added in proof." After the submission of this work for publication, a  report was 
published (Yarchoan, R., G. Tosato, R. M. Blaese, R. M. Simon, and D. L. Nelson. 
1983. Limiting dilution analysis of Epstein-Barr virus-induced immunoglobulin pro- 
duction by human B cells. J.  Exp.  Med.  157:1)  in which similar precursor frequency 
figures were presented for immunoglobulin secretion by Epstein-Barr virus activated 
human  B  cells, using an  assay system for secreted immunoglobulin  present  in cell 
culture supernatants, rather than a hemolytic plaque assay. 
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